PMC-403


Indications: Solid tumors / AMD


PMC-403 is a monoclonal antibody that targets the human Tie2 that regulate the angiogenesis and vessel maturation in endothelial cells.


Mechanism of action / Target

PMC-403 binds to TIE2 expressing endothelial cells that normalize VEGF-induced tumor vessel leakage in the tumor microenvironment (TME).


Status

PMC-403 was tested in various vessel-related disease such as age-related macular degeneration(AMD), diabetic retinopathy, and cancer. In these models, significant vessel normalizing effect was found which suggest versatile use in wide indications. GLP-toxicity study needed for the IND application will be completed in the near future.


LinkedIn  I   Facebook  I  YouTube



    • 2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil,
      Yuseong-gu, Daejeon, 34047, Republic of Korea
    • HQ +82-42-863-2017
    • R&D Center +82-42-861-2017
    • FAX +82-42-863-2080
  • COPYRIGHT BY PharmAbcine Inc. ALL RIGHTS RESERVED.